Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Brixmor Property Group Inc. reported net income of $87.8 million for the third quarter of 2026, a slight decrease from $94.2 million in the prior year period, despite a 5.3% increase in total revenues to $359.6 million. For the nine months ended September 30, 2026, net income rose to $289.0 million compared to $249.1 million in 2025, driven by higher rental income and gains on real estate sales.
Clearwater Paper reported Q3 2026 net sales of $385 million and a net loss of $2 million, or $0.10 per diluted share. Results were impacted by lower market pricing and operational disruptions at the Augusta mill, partially offset by improved average selling prices and insurance proceeds.
Term
Q3 2026
“We delivered strong commercial execution during the quarter, with average selling prices increasing versus the second quarter. We successfully implemented our first announced price increase and continue to make meaningful progress on implementing the second increase.”
Arsen Kitch, president and chief executive officer
“Our volumes and costs were negatively affected by a significant operational disruption at our Augusta mill late in the third quarter, with the impact being largely offset by a portion of RWI settlements. Operational Issues have continued into October, but we are making progress getting the mill back to normal operating conditions.”
Arsen Kitch, president and chief executive officer
The Hartford Insurance Group, Inc. reported its third quarter 2026 results, maintaining its status as a large accelerated filer with 267,413,397 shares of common stock outstanding as of October 23, 2026. The filing outlines significant risk factors including economic volatility, climate change impacts on weather patterns, and the integration of emerging technologies like artificial intelligence in underwriting.
MSCI General Counsel Robert J. Gutowski Sells $1.48M of Stock
Robert J. Gutowski, General Counsel, sold 2,381 shares of MSCI Inc. at $623.66 a share, worth $1.48M in total on Oct 22, 2026. Shares held after the trade: 14,104 (-14.4%).
Miami International Holdings EVP, GC & Corporate Secretary Barbara J. Comly Sells $431K of Stock
Barbara J. Comly, EVP, GC & Corporate Secretary, sold 12,306 shares of Miami International Holdings, Inc. at $35.04 a share, worth $431K in total on Oct 22, 2026. Shares held after the trade: 839,564 (-1.4%).
Sun Communities, Inc. reported its financial results for the third quarter and nine months ended September 30, 2026. The filing includes a formal condensed consolidated statement of operations and reconciliations for non-GAAP metrics such as Core FFO and NOI. The company scheduled an investor conference call for October 27, 2026, to discuss these results.
Agilysys reported record revenue of $93.4 million for its fiscal 2027 second quarter, representing 17.7% year-over-year growth. The company raised its full-year fiscal 2027 revenue guidance to a range of $374 million to $378 million and increased its subscription revenue growth outlook to at least 34%.
Term
Q2 2027
“Revenue was a record $93.4 million during Q2 Fiscal 2027, the 19th consecutive record revenue quarter, driven by subscription growth of 32.6%.”
Ramesh Srinivasan, President and CEO
“The second quarter of the fiscal year has continued to yield strong results. The teams are continuing to execute at elevated levels across the board, driven by a sustained high level of sales demand and project implementation velocity.”
Goldman Sachs Group Chief Administrative Officer Ericka T. Leslie Sells $223K of Stock
Ericka T. Leslie, Chief Administrative Officer, sold 250 shares of Goldman Sachs Group Inc at $890.03 to $890.85 a share (average $890.25) in 2 transactions, worth $223K in total on Oct 22, 2026. Shares held after the trade: 10,710 (-0.6%).
Citius Pharmaceuticals' subsidiary, Citius Oncology, reported preliminary fiscal fourth quarter 2026 operational metrics for its drug LYMPHIR. The company saw a 120% increase in unit sales to wholesalers (792 units) and expanded its institutional reach to 54 ordering centers as it works toward a goal of 100 priority institutions by year-end.
Citius Oncology reported preliminary fiscal fourth quarter 2026 operational metrics for its drug LYMPHIR, showing a 120% increase in unit sales to U.S. wholesalers compared to the prior quarter. The company reached 792 units sold to wholesalers and expanded its institutional reach to 54 prescribing centers as of late October.
BranchOut Food Inc. priced an underwritten public offering of 2,941,177 shares of common stock at $1.70 per share, raising approximately $5.0 million in gross proceeds. The company intends to use the net proceeds for working capital, general corporate purposes, and capital expenditures.
Wrap Technologies, Inc. increased its Board of Directors from six to seven members and appointed Edward Delatorre as a new director, effective October 20, 2026. In connection with his appointment, Mr. Delatorre was granted options to purchase 30,000 shares of common stock at an exercise price of $1.45 per share, vesting over a two-year period.
Silexion Therapeutics Corp shareholders approved a 1-for-24 reverse stock split of the company's ordinary shares, increasing the par value from $0.135 to $3.24 per share. Additionally, shareholders approved an increase in authorized share capital from 15.9 million to 515.9 million ordinary shares. The reverse split and capital increase were finalized at a reconvened extraordinary general meeting on October 26, 2026.
Oaktree Strategic Credit Fund declared a regular monthly distribution of $0.1600 per share for all share classes, payable on November 25, 2026, to shareholders of record as of October 28, 2026. The filing also provided a monthly update reporting a net asset value (NAV) of $22.24 per share as of September 30, 2026, and a total investment portfolio fair value of approximately $6.9 billion.
Eastgroup Properties EVP, CFO Staci H. Tyler Sells $323K of Stock
Staci H. Tyler, EVP, CFO, sold 1,600 shares of Eastgroup Properties Inc at $201.69 a share, worth $323K in total on Oct 23, 2026. Shares held after the trade: 13,584 (-10.5%).
Capital Bancorp reported Q3 2026 financial results with net income of $13.1 million and diluted EPS of $0.80. The quarter was highlighted by the announcement of a definitive merger agreement with Peoples Bancorp and the sale of its Chicago branch, alongside a newly declared quarterly dividend of $0.14 per share.
“This was indeed a very busy quarter with the announcements of the merger with Peoples Bank and the sale of our Chicago branch. However, it is also important to note our continued steady net interest margin and tangible net book value growth, along with sustained double-digit loan growth and the quarter-over-quarter increase in core earnings per share.”
Miami International Holdings EVP and CIO Douglas M. Schafer Jr. Sells $280K of Stock
Douglas M. Schafer Jr., EVP and CIO, sold 8,000 shares of Miami International Holdings, Inc. at $35.06 a share, worth $280K in total on Oct 22, 2026. Shares held after the trade: 387,414 (-2.0%).
CB Financial Services reported Q3 2026 net income of $5.3 million and adjusted EPS of $0.91, driven by six consecutive quarters of net interest income growth. The company also declared a quarterly cash dividend of $0.28 per share payable in November 2026. Management highlighted a balance sheet strategy focused on optimizing asset mix and growing core deposits through its Specialty Treasury clients.
Term
Q3 2026
“The Company’s balance sheet strategy remains centered on driving earnings growth within a disciplined, stable risk framework.”
John H. Montgomery, President and Chief Executive Officer
Hershey Insider Hershey Trust Co Trustee in Trust for Milton Hershey School Sells $3.45M of Stock
Hershey Trust Co Trustee in Trust for Milton Hershey School sold 20,000 shares of Hershey Co at $169.29 to $175.51 a share (average $172.46) in 14 transactions, worth $3.45M in total between Oct 22, 2026 and Oct 23, 2026. Shares held after the trade: 516,119 (-0.0%).
For the nine months ended September 30, 2026, Acumen Pharmaceuticals reported a net loss of $78.8 million, an improvement from the $96.2 million loss in the prior year period, primarily driven by a decrease in research and development expenses. The company's cash, cash equivalents, and marketable securities totaled $78.6 million as of September 30, 2026, down from $116.9 million at the end of 2025.
Cadence Design Systems reported Q3 2026 revenue of $1.633 billion, up 22% year-over-year, and raised its full-year 2026 revenue growth outlook to 21%. Alongside the results, the company announced that its board of directors authorized an additional $2.5 billion for its share repurchase program.
“Cadence delivered an outstanding third quarter. With broad-based business momentum, expanding technology leadership and a record backlog, we are raising our 2026 revenue outlook to 21% year-over-year growth. With the launch of Maestro, our portfolio of domain specialized AI models for chip and system design, and the accelerating deployment of our AI Super Agents, Cadence is exceptionally well positioned to capitalize on the transformational Agentic AI opportunity.”
Anirudh Devgan, president and chief executive officer
“Q3 revenue grew 22% year-over-year, with strong double-digit growth across all product categories, driven by growing momentum from AI-driven designs. With record backlog of $8.2 billion and continued strength in recurring revenue, we are poised to deliver a strong 2026.”
John Wall, senior vice president and chief financial officer
Kforce Inc. reported third quarter 2026 revenue of $357.8 million, representing a 7.5% year-over-year increase and exceeding the high end of its guidance. The growth was driven by a 7.8% year-over-year increase in Technology revenue and improved gross profit margins of 28.2%.
“We are extremely pleased to deliver a quarter of accelerating revenue and earnings growth. Revenues, which exceeded the high end of our guidance, reflect the continuing build of momentum that began in the second half of 2025, as evidenced by another quarter of sequential growth and further accentuated with a year-over-year growth rate in our Technology business of nearly 8% that is roughly equivalent to our pre-pandemic compound annual growth rate.”
Joseph J. Liberatore, President and Chief Executive Officer
“I am incredibly proud of the determination of our people and deeply appreciative of the trust our world-class clients continue to place in Kforce as we help them advance more meaningful, higher-value engagements. We believe our go-to-market approach, shaped by our integrated operating model, is gaining traction. Across the Firm, our people are operating more fully as "One Kforce," bringing the full breadth of our capabilities to bear across our service offerings.”
Joseph J. Liberatore, President and Chief Executive Officer
Crown Holdings, Inc. elected Wayne T. Smith to its Board of Directors and appointed him to the Audit Committee, effective October 21, 2026. Mr. Smith is the former Chairman and CEO of BASF Corporation and currently serves as Chairman of Air Products and Chemicals, Inc. His appointment increases the total number of board members to eleven.
Jazz Pharmaceuticals provided a preliminary update on its Q3 2026 financial results, estimating a $755 million pre-tax charge for acquired in-process research and development (IPR&D) related to its acquisition of Actio Biosciences. This non-deductible charge is expected to have an unfavorable impact of approximately $11.00 on both GAAP and non-GAAP adjusted earnings per share for the quarter.
InnovAge Holding CLO Nicole Damato Sells $32.4K of Stock
Nicole Damato, CLO, sold 3,402 shares of InnovAge Holding Corp. at $9.51 a share, worth $32.4K in total on Oct 22, 2026. Shares held after the trade: 301,495 (-1.1%).
Martin Midstream Partners L.P. reported a net loss of $4.1 million for the third quarter of 2026, an improvement from an $8.4 million loss in the prior year period. Total revenues increased significantly to $231.7 million from $168.7 million, driven primarily by higher specialty products and sulfur services sales, though operating expenses and cost of products sold also rose.
Check Point Software Technologies Chief Product Officer Nataly Kremer Sells $478K of Stock
Nataly Kremer, Chief Product Officer, sold 3,185 shares of Check Point Software Technologies Ltd at $150.08 a share, worth $478K in total on Oct 22, 2026. Shares held after the trade: 19,347 (-14.1%).
Avidbank Holdings reported Q3 2026 net income of $10.2 million, or $0.94 per diluted share, reflecting strong profitability and significant deposit growth. During the quarter, the company also redeemed $22.0 million in subordinated notes and completed a $30.0 million private placement of new subordinated notes maturing in 2036.
“We are very pleased with our third-quarter performance. We generated strong profitability while continuing to grow both loans and deposits, demonstrating the power of our ability to grow our franchise and the benefits of more consistent execution. The quarter’s deposit growth was exceptionally strong. A significant amount of that deposit growth came from a temporary large client deposit that we expect to leave in the fourth quarter, but our bankers also delivered meaningful core deposit growth across the franchise. The temporary deposit contributed to net interest income but created some pressure on our net interest margin.”
Mark Mordell, Chairman and Chief Executive Officer
“With strong capital, a diversified balance sheet and proactive credit management, we remain focused on generating consistent growth and creating long-term value for our shareholders.”
Mark Mordell, Chairman and Chief Executive Officer
United Community Banks EVP, Chief Banking Officer Richard Bradshaw Sells $49.8K of Stock
Richard Bradshaw, EVP, Chief Banking Officer, sold 1,339 shares of United Community Banks Inc at $37.17 a share, worth $49.8K in total on Oct 26, 2026. Shares held after the trade: 82,060 (-1.6%).
Principal Financial Group reported Q3 2026 net income of $632 million, or $2.91 per diluted share, and non-GAAP operating earnings of $2.22 per share. The company returned $429 million to shareholders during the quarter and announced a dividend increase to $0.85 per share for the fourth quarter.
Term
Q3 2026
“Our third-quarter results demonstrate the strength of our diversified business and the progress we’re making against our strategic priorities. We grew earnings per share, continued to build momentum in the markets where we’re focused, and returned $429 million to shareholders. We’re seeing the benefits of our focus on areas where our expertise, differentiated solutions, and strong customer relationships position us to win. As the environment evolves, our priorities remain clear. We’re confident in delivering on our 2026 outlook and continuing to create long-term value for our customers, employees, and shareholders.”
Deanna Strable, Chair, President and CEO of Principal